focus -WSS

focus

author：leisure time 2025-10-02 22:24:07 - browse：924

Christoph Lengauer stands for a portrait. -- biotech coverage from STAT — Christoph Lengauer, co-founder and CSO of Curie.Bio Vanessa Leroy for STAT

Curie.Bio, the new biotech investment firm and incubator launched earlier this year by a group of industry veterans including Alexis Borisy and Zach Weinberg, has graduated its first startup.

The startup, Forward Therapeutics, is coming out of the incubator with three drug candidates for chronic inflammatory disorders. It also just closed its first major financing round: a $50 million Series A round led by BVF Partners, with participation from RA Capital Management and OrbiMed. That money should be enough for Forward to begin clinical trials — a rare feat in the biotech world, where companies often need to raise multiple private financing rounds in order to be ready for human tests.

“Usually, with Series A money, you get a development candidate, and use Series B to take molecules to the clinic,” Forward CEO Toufike Kanouni told STAT. But with the Curie team’s help, and the $8 million in seed financing it provided, Forward was able to move much faster.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： Scientists unlock the key to scar

hotspot

leisure time

WSS

Medical device lobby: We're tired of waiting on Medicare coverage

The stability of $0 premiums in Medicare Advantage

International team creates first chimeric human

Why getting cancer drugs just got harder for rural patients

Stop Congress from blocking public access to science

Lawsuit highlights wrinkle for disputes over surprise medical bills

hotspot

focus

hotspot

The high cost of giving birth even with insurance

Health insurers' Q3 question: how much care are people getting?

In Memoriam: Notable people who died in 2023

Flu, Covid vaccination rates decline, new survey data show

Apple is now the first public company to be valued at $3 trillion

Congress extends some pandemic preparedness programs

23andMe had bad news about my health. I wish a person had delivered it

CDC picks Alphabet's Verily for wasterwater surveillance contract

Peter Hotez and the public health issue of online harassment

Congress gives doctors Medicare pay bump

leisure time

Why getting cancer drugs just got harder for rural patients

What we owe ALS patients — and why one company fell short

Why getting cancer drugs just got harder for rural patients

Obesity now affects over 1 billion people worldwide, study finds

CRISPR base editing slashes cholesterol levels in monkeys

FDA sees ‘potential systemic bias’ in Amgen’s KRAS drug trial

knowledge

hotspot

leisure time

entertainment